Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.

Mazahery H, Conlon C, Beck KL, Kruger MC, Stonehouse W, Camargo CA Jr, Meyer BJ, Tsang B, Mugridge O, von Hurst PR.

Trials. 2016 Jun 23;17(1):295. doi: 10.1186/s13063-016-1428-8.

2.

A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder.

Fristad MA, Young AS, Vesco AT, Nader ES, Healy KZ, Gardner W, Wolfson HL, Arnold LE.

J Child Adolesc Psychopharmacol. 2015 Dec;25(10):764-74. doi: 10.1089/cap.2015.0132.

PMID:
26682997
3.

Potential serum biomarkers from a metabolomics study of autism.

Wang H, Liang S, Wang M, Gao J, Sun C, Wang J, Xia W, Wu S, Sumner SJ, Zhang F, Sun C, Wu L.

J Psychiatry Neurosci. 2016 Jan;41(1):27-37.

4.

Complementary and Alternative Therapies for Autism Spectrum Disorder.

Brondino N, Fusar-Poli L, Rocchetti M, Provenzani U, Barale F, Politi P.

Evid Based Complement Alternat Med. 2015;2015:258589. doi: 10.1155/2015/258589. Epub 2015 May 7. Review.

5.

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.

Mankad D, Dupuis A, Smile S, Roberts W, Brian J, Lui T, Genore L, Zaghloul D, Iaboni A, Marcon PM, Anagnostou E.

Mol Autism. 2015 Mar 21;6:18. doi: 10.1186/s13229-015-0010-7. eCollection 2015.

6.
7.

Soy Infant Formula may be Associated with Autistic Behaviors.

Westmark CJ.

Autism Open Access. 2013 Nov 18;3. pii: 20727.

8.
9.

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.

Bent S, Hendren RL, Zandi T, Law K, Choi JE, Widjaja F, Kalb L, Nestle J, Law P.

J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):658-66. doi: 10.1016/j.jaac.2014.01.018. Epub 2014 Mar 12.

10.

Evolving the future: toward a science of intentional change.

Wilson DS, Hayes SC, Biglan A, Embry DD.

Behav Brain Sci. 2014 Aug;37(4):395-416. doi: 10.1017/S0140525X13001593. Epub 2014 May 15. Review.

11.

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, Coben R, Lewine J, Slattery JC, Lau C, Hardy P, Fatemi SH, Folsom TD, Macfabe D, Adams JB.

Front Public Health. 2013 Sep 13;1:31. doi: 10.3389/fpubh.2013.00031. Review.

12.

Autism spectrum disorders.

Fitzgerald K, Hyman M, Swift K.

Glob Adv Health Med. 2012 Sep;1(4):62-74. doi: 10.7453/gahmj.2012.1.4.010.

13.

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.

Lotrich FE, Sears B, McNamara RK.

J Psychosom Res. 2013 Nov;75(5):475-83. doi: 10.1016/j.jpsychores.2013.07.012. Epub 2013 Jul 26.

14.

The role of nutraceuticals in the management of autism.

Alanazi AS.

Saudi Pharm J. 2013 Jul;21(3):233-43. doi: 10.1016/j.jsps.2012.10.001. Epub 2012 Oct 23. Review.

15.

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.

Macfabe DF.

Microb Ecol Health Dis. 2012 Aug 24;23. doi: 10.3402/mehd.v23i0.19260. eCollection 2012.

16.

Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features.

Ghezzo A, Visconti P, Abruzzo PM, Bolotta A, Ferreri C, Gobbi G, Malisardi G, Manfredini S, Marini M, Nanetti L, Pipitone E, Raffaelli F, Resca F, Vignini A, Mazzanti L.

PLoS One. 2013 Jun 19;8(6):e66418. doi: 10.1371/journal.pone.0066418. Print 2013.

17.

A review of complementary and alternative treatments for autism spectrum disorders.

Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E.

Autism Res Treat. 2012;2012:870391. doi: 10.1155/2012/870391. Epub 2012 Nov 28.

18.

The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.

Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S, MacFabe DF.

J Neuroinflammation. 2012 Jul 2;9:153. doi: 10.1186/1742-2094-9-153.

19.

(N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.

Prior PL, Galduróz JC.

Adv Nutr. 2012 May 1;3(3):257-65. doi: 10.3945/an.111.001693. Review.

20.

Review of the pharmacotherapy of irritability of autism.

Elbe D, Lalani Z.

J Can Acad Child Adolesc Psychiatry. 2012 May;21(2):130-46.

Items per page

Supplemental Content

Write to the Help Desk